Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposiʼs sarcoma - Concepedia

Concepedia

Publication | Closed Access

Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposiʼs sarcoma

39

Citations

0

References

1994

Year

Parkash S. Gill, Steven A. Miles, Ronald T. Mitsuyasu, Terri Montgomery, Suzie McCarthy, Byron M. Espina, Michael Feldstein, Alexandra M. Levine

Abstract

The maximum tolerated dose of doxorubicin is 10 mg/m2 when given in combination with zidovudine and BV chemotherapy. Response rates observed with the combined antiretroviral and chemotherapy regimen are similar to those previously reported with ABV chemotherapy alone.